{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/globalization-clinical-trials-giving-more-patients-access-cancer-therapies-point-clinical#webpage",
"url": "https://www.fortrea.com/insights/globalization-clinical-trials-giving-more-patients-access-cancer-therapies-point-clinical",
"name": "Globalization of Clinical Trials: Giving More Patients Access to Cancer Therapies at the Point of Clinical Decision Making",
"description": "This Fortrea Info Sheet explores strategies for expanding patient access to cancer clinical trials by bringing research closer to where patients receive care and improving participation opportunities across diverse populations. As oncology research becomes increasingly complex, sponsors must address barriers related to geography, site availability, referral pathways, and patient awareness to improve recruitment and enrollment outcomes. The information sheet highlights how global research networks, community-based oncology sites, patient-centric trial models, and innovative recruitment strategies can help identify eligible patients earlier, increase access to investigational therapies, and accelerate enrollment timelines. It also examines the role of optimized site selection, broader geographic reach, and integrated patient engagement approaches in improving trial accessibility while supporting diversity and inclusion objectives. By expanding oncology clinical research beyond traditional academic centers and closer to the point of care, sponsors can improve patient participation, strengthen study performance, and accelerate the development of innovative cancer therapies for patients worldwide."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Globalization of Clinical Trials: Giving More Patients Access to Cancer Therapies at the Point of Clinical Decision Making",
"item": "https://www.fortrea.com/insights/globalization-clinical-trials-giving-more-patients-access-cancer-therapies-point-clinical"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/globalization-clinical-trials-giving-more-patients-access-cancer-therapies-point-clinical#infosheet",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/globalization-clinical-trials-giving-more-patients-access-cancer-therapies-point-clinical#webpage"
},
"headline": "Globalization of Clinical Trials: Giving More Patients Access to Cancer Therapies at the Point of Clinical Decision Making",
"description": "This Fortrea Info Sheet explores strategies for expanding patient access to cancer clinical trials by bringing research closer to where patients receive care and improving participation opportunities across diverse populations. As oncology research becomes increasingly complex, sponsors must address barriers related to geography, site availability, referral pathways, and patient awareness to improve recruitment and enrollment outcomes. The information sheet highlights how global research networks, community-based oncology sites, patient-centric trial models, and innovative recruitment strategies can help identify eligible patients earlier, increase access to investigational therapies, and accelerate enrollment timelines. It also examines the role of optimized site selection, broader geographic reach, and integrated patient engagement approaches in improving trial accessibility while supporting diversity and inclusion objectives. By expanding oncology clinical research beyond traditional academic centers and closer to the point of care, sponsors can improve patient participation, strengthen study performance, and accelerate the development of innovative cancer therapies for patients worldwide.",
"genre": "Info Sheet",
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-07-12",
"dateModified": "2025-07-12",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2026-04/clinical-trials-patient-access-cancer-10-04-2026.pdf",
"encodingFormat": "application/pdf"
}
}
]
}